Skip to main content
. Author manuscript; available in PMC: 2010 Jul 9.
Published in final edited form as: Oncol Rep. 2010 Jul;24(1):15–24. doi: 10.3892/or_00000823

Table II.

Comparison of changes in gene expression (increase or decrease relative to untreated control)a in A2780 cells following treatment with Pt (II) spermine, Pd (II) spermine and Cispt, DENSPM or Cispt/DENSPM under the same treatment conditions

Gene CisPt DENSPM CisPt/DEN Pt (II)-spermine Pd (II)-spermine
SSAT 33 3 49 NC NC
SMO 6 3 5.9 0.18 0.13
SAMDC 0.6 NC 0.5 NC NC
ARG2 2.3 NC 2.4 0.33 0.38
NRF2 1.75 NC 2.1 0.42 0.46
FAS 16 NC 17 1.7 NC
BAX 4.5 NC 3.5 1.7 1.5
BCL2 0.43 NC 0.37 0.5 0.5
BIRC5 (Survivin) 0.3 NC 0.4 NC NC
P21 93 NC 51 5 2.7
MDM2 26 NC 29.7 NC NC
PCNA 3.3 NC 2.8 1.5 1.6
ERCC1 4 NC 2.6 0.6 0.6
GGT1 NC NC NC 0.23 0.25
OCT,1 3 NC 2.3 NC NC
OGG1 NC NC 0.6 0.65 0.62
PPARG NC NC 0.5 0.6 NC
PTGS2 (Cox2) 1.8 0.7 NC 0.45 0.4
a

Values are RQ (relative expression, treated/control); rounded off. NC, no change. RQ value >1 denotes up-regulation and the value itself describes the fold increase in expression; RQ value <1 denotes down-regulation and the value itself is expression as a fraction of control.